Provided by Tiger Fintech (Singapore) Pte. Ltd.

Voya Global Advantage and Premium Opportunity Fund

9.81
+0.09010.93%
Volume:117.54K
Turnover:1.15M
Market Cap:178.54M
PE:14.05
High:9.83
Open:9.70
Low:9.68
Close:9.72
Loading ...

Quoin Pharmaceuticals Announces Positive Interim Data from Two Ongoing Netherton Syndrome Clinical Studies

GlobeNewswire
·
18 Dec 2024

Corvus Pharmaceuticals Announces Interim Data from Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis

GlobeNewswire
·
18 Dec 2024

Press Release: Voya Global Advantage and Premium Opportunity Fund & Voya Infrastructure, Industrials and Materials Fund Announce Payment of Monthly Distribution

Dow Jones
·
17 Dec 2024

Press Release: Voya Equity Closed End Funds Declare Distributions

Dow Jones
·
17 Dec 2024

Dermata Receives Approval from FDA for the Proprietary Name Xyngari(TM)

ACCESSWIRE
·
16 Dec 2024

NTT Group Chooses Evidian Identity Governance & Administration as the Cornerstone of their Identity Management Infrastructure in Japan

GlobeNewswire
·
10 Dec 2024

Dermata Completes Enrollment in First Pivotal DMT310 Phase 3 STAR-1 Clinical Trial for Acne

ACCESSWIRE
·
03 Dec 2024

Seequent and the International Geothermal Association Partner to Unlock Geothermal Energy's Potential for a Sustainable Future

Business Wire
·
21 Nov 2024

Icotrokinra delivered an industry-leading combination of significant skin clearance with demonstrated tolerability in a once daily pill in Phase 3 topline results

PR Newswire
·
19 Nov 2024

Press Release: Voya Equity Closed End Funds Declare Distributions

Dow Jones
·
16 Nov 2024

Press Release: VOYA GLOBAL ADVANTAGE AND PREMIUM OPPORTUNITY FUND & VOYA INFRASTRUCTURE, INDUSTRIALS AND MATERIALS FUND ANNOUNCES PAYMENT OF MONTHLY DISTRIBUTION

Dow Jones
·
16 Nov 2024